Some US states still pushing ineffective covid antibody treatment

the latest tech news, global tech news daily, tech news today, startups, usa tech, asia tech, china tech, eu tech, global tech, in-depth electronics reviews, 24h tech news, 24h tech news, top mobile apps, tech news daily, gaming hardware, big tech news, useful technology tips, expert interviews, reporting on the business of technology, venture capital funding, programing language

Some US states still pushing ineffective covid antibody treatment
© Provided by Quartz A bag of golden/brown plasma hanging in an IV drip. As the omicron variant completes its sweep across the U.S., states with scarce supplies of monoclonal antibody therapies continue to use two treatments that federal health officials warn no longer work against the highly contagious version of the virus that causes covid-19. The antibody treatment now most recommended is sotrovimab from GlaxoSmithKline and Vir Biotechnology, and it’s in short supply.

Use of the newly ineffective treatments produced by Regeneron Pharmaceuticals and Eli Lilly and Co. is highest in a dozen states. They include several Southern states with some of the nation’s lowest vaccination rates, but also California, which ranks in the nation’s top 20 for fully vaccinated residents, a KHN analysis of federal data shows. Many hospitals and clinics are still infusing the costly treatments — often charging hundreds of dollars a session — that public health officials now say are almost certainly useless.

the latest tech news, global tech news daily, tech news today, startups, usa tech, asia tech, china tech, eu tech, global tech, in-depth electronics reviews, 24h tech news, 24h tech news, top mobile apps, tech news daily, gaming hardware, big tech news, useful technology tips, expert interviews, reporting on the business of technology, venture capital funding, programing language

That’s because of the near-total dominance of omicron, which accounted for 99.5% of new covid infections in the U.S. during the week that ended Jan. 15, according to the Centers for Disease Control and Prevention.

That point was underscored this week by updated guidelines from the National Institutes of Health that now recommend sotrovimab as the primary monoclonal treatment for the disease.

Global Tech News Daily

Unless providers are certain they are still treating patients infected with the delta variant, they shouldn’t use the others, said Dr. Mark McClellan, director of the Duke-Margolis Center for Health Policy, who is also a former commissioner of the FDA and former administrator of CMS. And the delta variant is increasingly rare, accounting for 3% of cases in Louisiana, 7% in California, and 10% in Ohio, as examples.

“There’s not a medical justification based on the evidence on the Regeneron and Lilly products,” McClellan said.

Global Tech News Daily

Determining which patients are infected with the delta vs. omicron variant is complicated, said Dr. Christian Ramers, chief of population health and an infectious disease specialist at Family Health Centers of San Diego.

His clinic is one of the few sites in the nation using laboratory screening of positive PCR covid tests that can tell whether patients are infected with delta vs. omicron — and then treating them accordingly. “Otherwise, you’re giving this false sense of security to a patient that they’re getting treatment,” Ramers said. “I don’t think it is ethical, and it goes against the principle of doing no harm.”

Overall, U.S. hospitals used about 72,000 doses of the Regeneron and Lilly monoclonal antibody therapies from Jan. 5 through Jan. 18, according to the latest figures from the Department of Health and Human Services. Data regarding hospital-level use of sotrovimab, which became available more recently than the other products, is not yet available on the HHS site.

By comparison, hospitals used about 153,000 courses of the Regeneron and Lilly treatments from Dec. 22 through Jan. 4. They used about 169,000 courses from Aug. 26 through Sept. 8, near the height of the delta surge.

On Jan. 19, hospitals still had about 295,000 doses of the Regeneron and Lilly treatments on hand.

Nationwide, the federal government is distributing more than 50,000 courses of sotrovimab per week, though it remains in short supply. The Biden administration has agreed to buy about 1 million doses, including about 600,000 promised by March, GSK officials said.

Respectively, Michigan, Florida, Indiana, Missouri, Louisiana, California, Oklahoma, Kansas, Georgia, Ohio, New York, and Mississippi used the most courses of the Regeneron and Lilly treatments from Jan. 5 through Jan. 18, KHN’s analysis showed.

In Florida, which used more than 5,200 courses of the outdated treatments during that two-week period, Republican Gov. Ron DeSantis has said he is not convinced that the Regeneron and Lilly products don’t work against omicron. In Florida, omicron accounted for 97% of cases as of Jan. 20; delta accounted for 3%.

“We have had practitioners give both of those to people with omicron who said the symptoms got resolved,” he said in a Jan. 5 speech provided by his spokesperson, Christina Pushaw.

Federal health officials managing allocation of the monoclonal antibody therapies paused shipments of the Regeneron and Lilly treatments on Dec. 23, after laboratory tests showed they were less effective against the surging omicron variant than the delta variant. But the Biden administration resumed shipments on Dec. 31, after complaints from DeSantis and some doctors that those therapies could still help people in places where the delta variant persisted.

Regeneron itself has said its antibody treatments are ineffective against the omicron variant. It contains more than 30 mutations in the virus’s spike protein, which makes the variant better at dodging the monoclonal antibody treatments.

“It’s really not justified at this point unless there’s some other underlying secondary gain, political pressure, or perhaps the providers are truly not in touch with the reality of the variant proportions,” Ramers said.

Earlier this month, HHS officials indicated that shipments of the three monoclonal antibody treatments would continue through Jan. 31, despite the growing proportion of omicron cases. A department spokesperson on background said the agency would continue to assess “any impacts to covid-19’s therapeutic allocations.”

Monoclonal antibody treatments are lab-based molecules that mimic the body’s immune response to infection. They are most often given through IV infusion, though some can be delivered with an injection. The federal government has agreed to purchase millions of doses of the Regeneron and Lilly products at a cost of about $2,100 per dose. The medicines are free to consumers, though hospitals and clinics do charge fees for administering the drugs and monitoring patients during the process.

Other treatments expected to be effective against omicron in high-risk, non-hospitalized patients include AstraZeneca’s Evusheld, a long-acting injectable monoclonal antibody for immunocompromised people, and a three-day infusion of Gilead Sciences’ remdesivir, which is approved by the FDA. New oral antiviral pills also are expected to be effective, although they, too, remain in short supply.

Providers in several states that have continued to use the Regeneron and Lilly products have offered varied reasons. Some said they believed delta infections continued to circulate locally; others said they felt desperate to try something.

Officials in Michigan, which used more than 5,800 doses of the Regeneron and Lilly products during the most recent two weeks, and California, which used more than 3,400, have allowed health care providers to use their clinical judgment about which treatment to prescribe.

But in Mississippi, where omicron is rampant and fewer than half of residents have been fully vaccinated, state health officer Dr. Thomas Dobbs called for an end to the use of the treatments.

“We will be recommending that clinicians and physicians do not use these products right now based on the distribution of omicron vs. delta,” he said during a recent press conference.

At Ramers’ clinic in San Diego, care providers have been dispensing scarce doses of the monoclonal antibody treatments only when they’re confident they’ll help. That has meant sending batches of positive PCR tests to a laboratory in nearby Irvine, where they are screened to see whether one of three target genes is not detected, a known marker for an omicron infection.

Patients infected with the delta variant were able to be treated with REGEN-COV, the Regeneron product, preserving sotrovimab for the growing number of omicron cases, said Pauline Lucatero, the clinic’s director of nursing.

“Looking into my patients’ eyes and seeing fear, just fear, all I could tell them is we believe this treatment works and we’re going to do everything we can to save as many people as we can,” she said.

Phillip Reese, an assistant professor of journalism at California State University-Sacramento, contributed to this report.

This article is republished from Kaiser Health News under a Creative Commons license. Read the original article.

News Related

OTHER NEWS

Third Ebola patient dies in DR Congo

The third Ebola patient in northwest Democratic Republic of Congo has died, the World Health Organisation says, the latest fatality in an outbreak first reported last month. The 48-year-old man ... Read more »

UK Labour leader probed on 'virus breach'

UK police say they will investigate opposition leader Keir Starmer over a potential breach of COVID-19 lockdown rules in 2021 after receiving significant new information, delivering an embarrassing blow to ... Read more »

Beijing nervous, COVID cases not dropping

Beijing residents are fretting over tightening COVID-19 curbs in its biggest district and dozens of new cases reported daily as China's leaders reiterated their resolve to battle the virus and ... Read more »

US health authorities warn of clot peril with Johnson & Johnson COVID vaccine

Blood clots have ended high hopes for Johnson & Johnson’s one-shot vaccine vaccine. Photo: Getty Live US regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due ... Read more »

Far West hospitality venues feeling impacts of COVID on staffing numbers and work

Far west hospitality venues say they are running on bare minimum staffing numbers as COVID impacts their operations. Key points: A number of local venues are considering, or have reduced, their opening ... Read more »

COVID in WA: Third dose vaccine milestone reached as daily cases fall below 10,000

WA has marked a long-awaited vaccine milestone, a day after COVID cases reached a record peak. The Health Department has reported the third dose vaccination rate has reached 80.1 per ... Read more »

FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot risk

The Food and Drug Administration put rigid limits on who can receive Johnson & Johnson’s one-dose COVID-19 vaccine on Thursday, saying the vaccine should only be given to people who ... Read more »

WHO says true pandemic death toll is 15 million — not six million

Live Nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems during the first two years of the pandemic,  the World Health Organisation estimates. ... Read more »

WHO links 14.9mln deaths to COVID-19

Nearly 15 million people were killed either by coronavirus or by its impact on overwhelmed health systems during the first two years of the pandemic, the World Health Organisation estimates. ... Read more »

Eleven African countries in 5th COVID wave

COVID-19 infections are on the rise in Africa but are becoming less and less fatal, an Africa CDC official says. Countries experiencing their fifth wave of cases are seeing tallies ... Read more »

Omicron 'just as severe', US study says

The Omicron variant of COVID-19 is intrinsically as severe as previous variants, unlike assumptions made in previous studies that it was more transmissible but less severe, a large study in ... Read more »

Elderly man in Shanghai wakes up in a hearse on the way to the morgue after wrongly being declared dead

COVID has taken a huge toll on the elderly all over the world. But it appears the authorities in China may have been a little over-zealous in the case of ... Read more »

‘No end in sight’: In Beijing, fears of Shanghai-style lockdown

Officials in Chinese capital have designated 518 coronavirus outbreak sites amid growing fears of a city-wide lockdown. Read more »

COVID in WA: State reports more than 10,000 daily cases for first time in the coronavirus pandemic

WA has reported more than 10,000 daily cases of COVID for the first time in the pandemic, just days after the mask mandate and other restrictions were dropped. WA Health ... Read more »

Western Australia records more than 10,000 new Covid-19 cases

Western Australia has recorded 10,000 new cases of Covid-19 overnight, surpassing the original prediction for the peak of the Omicron wave. The spike in infections comes less than one week ... Read more »

NSW push vaccines with flu on the rise

Cases of flu in NSW have more than doubled in recent weeks, leading to a spike of hospitalisations. Chief Health Officer Kerry Chant said there were more than 1024 cases ... Read more »

Victoria becomes the first state to record over 3000 Covid deaths

Victoria has hit an unwanted Covid milestone after becoming the first Australian jurisdiction to record over 3000 deaths due to the virus. The Victorian Department of Health reported 14 new ... Read more »

IMAGE: Pilot program offers free flu vaccines

IMAGE: Pilot program offers free flu vaccines News Video Read more »

Can I get the flu jab if I've just had COVID-19? What you need to know about winter with both viruses

Flu season has officially arrived, with Australia already seeing thousands of cases of the virus. Both COVID-19 and influenza are now circulating in the community, and health authorities are pleading with people to ... Read more »

US Secretary of State Blinken has COVID-19

The US State Department says Secretary of State Antony Blinken has tested positive for COVID-19 after attending the White House Correspondents' Dinner and related events over the weekend. Spokesman Ned ... Read more »

Virus cases dip except in Americas, Africa

The World Health Organisation says the number of newly reported coronavirus cases and deaths globally has continued to fall in the last week, continuing a decline that first began in ... Read more »

COVID in WA: State tallies record 9782 daily coronavirus cases

WA has reported a record 9782 daily COVID infections less than a week after dropping the majority of restrictions designed to contain the virus. However, the number of people in ... Read more »

SA to change virus management

South Australia will change how it handles the ongoing COVID-19 pandemic as it prepares to end the state's emergency management declaration. The new Labor government has introduced legislation to amend ... Read more »

Three new Omicron subvariants in Australia

Three new Omicron subvariants have reached Australia and health authorities say people who contract the virus should wait three months before getting their next COVID-19 vaccination. Associate Professor Stuart Turville ... Read more »

Outcome on COVID vaccine IP waiver: WTO

The four main parties to negotiations on an intellectual property waiver for COVID-19 vaccines have prepared an “outcome document” for approval by the broader membership. World Trade Organisation director-general Ngozi ... Read more »

Beijing tests, Shanghai eases some curbs

Some of Shanghai's 25 million people have managed to get out for short walks and shopping after enduring more than a month under a COVID-19 lockdown while China's capital Beijing ... Read more »

Regional post-COVID mental health crisis

The demand for regional mental health services has spiked since the coronavirus pandemic, forcing many psychologists to close their books because they can't keep up. It's been described as a ... Read more »

Beijing preparing for major COVID-19 spike

Beijing is preparing new hospital facilities to deal with a spike in COVID-19 cases, even though the numbers of new cases remain low. A 1000-bed hospital at Xiaotangshan in the ... Read more »

Experts warn of possible renewed flu spike

Health experts are warning of a renewed spread of seasonal flu after two years of COVID-19 restrictions left fertile ground for the potentially deadly bug to spread. The number of ... Read more »

Hong Kong to further ease COVID curbs

Hong Kong will further ease COVID-19 restrictions, allowing bars to open until 2am and doubling the number of diners permitted at a table, as cases in the global financial hub ... Read more »

ACT to drop COVID-19 vaccine mandates for healthcare workers, teachers in Canberra

Workers in healthcare and education settings across Canberra will soon no longer be required to be vaccinated against COVID-19, the ACT Health Minister has announced. Key points: Workers in disability and ... Read more »

Victoria and NSW record almost 20,000 Covid cases in 24 hours

Victoria and NSW have experienced big increases in their daily Covid numbers, with the states recording more than 19,000 new cases combined. NSW recorded 9656 infections in the 24 hours ... Read more »

COVID in WA: Infections track up with one historical death reported

Reported COVID infections tracked back up on Tuesday to 7929 with small increases also recorded in the number of people in hospital and ICU. One historical death was also reported, ... Read more »

COVID variants detected in SA for first time as health authorities also prepare for flu

South Australia's public health chief has issued a warning to parents about reduced flu immunity ahead of winter, as new COVID variants are detected in the state. Key points: SA has recorded its ... Read more »

COVID-19, flu winter resurgence predicted

Authorities are warning the easing of COVID-19 restrictions will see a spike in transmissions as well as a resurgence of flu this winter. Acting Australian Chief Medical Officer Sonya Bennett ... Read more »

Coronavirus Watch: Catch COVID this summer? Don't expect an Airbnb refund

If you catch COVID-19 ahead of your summer vacation, don’t expect an Airbnb refund. More than two years after the start of the COVID-19 pandemic, Airbnb says it will no ... Read more »

COVID setback for Shanghai, Beijing braces

China's commercial capital of Shanghai has been dealt a blow as authorities reported 58 new COVID-19 cases outside quarantine areas, while Beijing pressed on with testing millions of its people ... Read more »

Tourists return as NZ pandemic rules ease

New Zealand has welcomed back tourists from the US, Canada, Britain, Japan and more than 50 other countries for the first time in more than two years after dropping most ... Read more »

'Unprecedented' code white for three days as Mount Gambier hospital battles staffing shortages

South Australia's largest regional hospital was placed under a code white rating for three days last week, in what is understood to be a first for the facility.  Key points: ... Read more »

COVID in WA: Elective surgery opens up as virus cases remain steady

WA has recorded 5847 new COVID cases and zero deaths to 8pm on Sunday night, as private hospitals resume taking bookings for elective surgery for non-essential procedures. The numbers are ... Read more »